NCT00744081View on ClinicalTrials.gov

Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML)

PHASE2CompletedINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

AML

Interventions

DRUG

Glivec

DRUG

Mitoxantrone

DRUG

Topotecan

DRUG

AraC

Trial Locations (1)

Unknown

University of Frankfurt, Medical Dept. II, Frankfurt

Sponsors

Lead Sponsor

Goethe University

All Listed Sponsors

lead

Goethe University

OTHER